H. Müller-Alouf

发表

Cytokines in Streptococcal Infections

J. Cavaillon, H. Müller-Alouf, J. Alouf, 1997 .

Lactic acid bacteria as live vaccines.

H. Müller-Alouf, A. Mercenier, C. Grangette, 2000, Current issues in molecular biology.

Staphylococcal and streptococcal superantigens: molecular, biological and clinical aspects.

H. Müller-Alouf, J. Alouf, 2003, International journal of medical microbiology : IJMM.

Superantigen bacterial toxins: state of the art.

H. Müller-Alouf, J. Alouf, M. Simonet, 2001, Toxicon : official journal of the International Society on Toxinology.

Streptococcal pyrogenic exotoxin A, streptolysin O, exoenzymes, serotype and biotype profiles of Streptococcus pyogenes isolates from patients with toxic shock syndrome and other severe infections.

H. Müller-Alouf, J. Alouf, P. Geslin, 1997, Zentralblatt fur Bakteriologie : international journal of medical microbiology.

Serotype, biotype, pyrogenic exotoxin, streptolysin O and exoenzyme patterns of invasive Streptococcus pyogenes isolates from patients with toxin shock syndrome, bacteremia and other severe infections.

H. Müller-Alouf, J. Alouf, P. Geslin, 1997, Advances in experimental medicine and biology.

Erythrogenic toxin type A (ETA): epidemiological analysis of gene distribution and protein formation in clinical Streptococcus pyogenes strains causing scarlet fever and the streptococcal toxic shock-like syndrome (TSLS).

H. Müller-Alouf, W. Köhler, W. Reichardt, 1993, Zentralblatt fur Bakteriologie : international journal of medical microbiology.

Cytokine production by murine cells activated by erythrogenic toxin type A superantigen of Streptococcus pyogenes.

J. Cavaillon, C. Fitting, H. Müller-Alouf, 1992, Immunobiology.

CHAPTER 49 – What are superantigens?

H. Müller-Alouf, J. Alouf, 2006 .

Streptococcus, Group A

H. Müller-Alouf, J. Alouf, 2004 .

Circulating growth-regulator oncogene alpha contributes to neutrophil priming and interleukin-8-directed mucosal recruitment into chronic lesions of patients with Crohn's disease.

P. Desreumaux, M. Capron, H. Müller-Alouf, 1999, European cytokine network.

Comparative study of cytokine release by human peripheral blood mononuclear cells stimulated with Streptococcus pyogenes superantigenic erythrogenic toxins, heat-killed streptococci, and lipopolysaccharide

J. Cavaillon, C. Fitting, H. Müller-Alouf, 1994, Infection and immunity.

Mucosal Immune Responses and Protection against Tetanus Toxin after Intranasal Immunization with Recombinant Lactobacillus plantarum

H. Müller-Alouf, A. Mercenier, C. Grangette, 2000 .

The superantigenic toxin of Yersinia pseudotuberculosis: a novel virulence factor?

P. Desreumaux, H. Müller-Alouf, C. Grangette, 2000, International journal of medical microbiology : IJMM.

Streptococcal pyrogenic exotoxin A (SPE A) superantigen induced production of hematopoietic cytokines, IL-12 and IL-13 by human peripheral blood mononuclear cells.

P. Desreumaux, M. Capron, H. Müller-Alouf, 1997, Microbial pathogenesis.

Is a dominant superantigen involved in AIDS pathogenesis?

L. Montagnier, H. Müller-Alouf, M. Gougeon, 1993, The Lancet.

[Cellular constituents and extracellular proteins involved in the pathogenic capacity of Streptococcus group A].

H. Müller-Alouf, J. Alouf, 1996, Annales pharmaceutiques francaises.

Human pro- and anti-inflammatory cytokine patterns induced by Streptococcus pyogenes erythrogenic (pyrogenic) exotoxin A and C superantigens

J. Cavaillon, C. Fitting, H. Müller-Alouf, 1996, Infection and immunity.

Inflammatory alterations in mesenteric adipose tissue in Crohn's disease.

J. Auwerx, P. Desreumaux, M. Capron, 1999, Gastroenterology.

Superantigen YPMa Exacerbates the Virulence ofYersinia pseudotuberculosis in Mice

E. Leteurtre, H. Müller-Alouf, M. Simonet, 2000, Infection and Immunity.

Protection against tetanus toxin after intragastric administration of two recombinant lactic acid bacteria: impact of strain viability and in vivo persistence.

H. Müller-Alouf, A. Mercenier, C. Grangette, 2002, Vaccine.

Cytokine profile of human peripheral blood mononucleated cells stimulated with a novel streptococcal superantigen, SPEA, SPEC and group A streptococcal cells.

J. Cavaillon, M. Capron, C. Fitting, 1997, Advances in experimental medicine and biology.

Pyrogenicity and Cytokine-Inducing Properties ofStreptococcus pyogenes Superantigens: Comparative Study of Streptococcal Mitogenic Exotoxin Z and Pyrogenic Exotoxin A

J. Cavaillon, P. Desreumaux, C. Fitting, 2001, Infection and Immunity.

Erythrogenic toxins A, B and C: occurrence of the genes and exotoxin formation from clinical Streptococcus pyogenes strains associated with streptococcal toxic shock-like syndrome.

H. Müller-Alouf, J. Alouf, W. Köhler, 1992, FEMS microbiology letters.

Enhanced Mucosal Delivery of Antigen with Cell Wall Mutants of Lactic Acid Bacteria

H. Müller-Alouf, A. Mercenier, C. Grangette, 2004, Infection and Immunity.

Mucosal Immune Responses and Protection against Tetanus Toxin after Intranasal Immunization with RecombinantLactobacillus plantarum

H. Müller-Alouf, A. Mercenier, C. Grangette, 2001, Infection and Immunity.